Canada's Nuclear Reactor

August 13, 2009 - The Canadian Prime Minister Stephen Harper expressed disappointment with reports from the Atomic Energy of Canada Ltd. (AECL) that the aging nuclear reactor at Chalk River, Ontario, which produces most of the medical isotopes for Canada and the United States, will not be back up and running until the spring of 2010.

In the meantime, doctors will have to be patient, as technetium-99 supplies are rationed. The reactor produces medical isotopes such as molybdenum-99 (Mo-99), which produce technetium-99 used in diagnostic nuclear imaging scans.

The AECL identified nine sites at the reactor in need of repair. Corrosion experts are advising the AECL, as the group works closely with the Canadian Nuclear Safety Commission, whose safety inspectors are directly involved at the Chalk River site.

The AECL assured the Canadians that the repairs are not a public safety issue, adding there is no threat to workers on site or the environment.

The Canadian ministers of health and natural resources had issued a joint statement Wednesday night saying they're disappointed that the Chalk River facility won't be back online until the first quarter of 2010.

For more information: www.aecl.ca/


Related Content

News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | PET Imaging

February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before ...

Time February 09, 2024
arrow
News | Interventional Radiology

February 6, 2024 — RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology ...

Time February 06, 2024
arrow
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
News | Radiology Business

January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals ...

Time January 23, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

January 18, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved expanded MRI labeling ...

Time January 18, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
arrow
Subscribe Now